Multi-center outcomes-based clinical evaluation of the VITROS® immunodiagnostic products Anti-HAV IgM assay (VITROS Anti-HAV IgM assay) in subjects at high or low risk for hepatitis A, or positive for IgM antibody to hepatitis a virus (Anti-HAV IgM).

被引:0
|
作者
Calcagno, J. V.
Schiff, E.
Gorlin, J. B.
Uettwiller-Geiger, D.
Yee, H. F., Jr.
Kasahara, N.
Attar, B.
Ansari, M. Q.
McFarland, R.
Latimer, M. J.
Bergmeyer, L.
Laird, E.
John, B.
Boyer, B.
DeLucia, M.
机构
[1] Ortho Clin Diagnost, Raritan, NJ USA
[2] Univ Miami, Sch Med, Ctr Liver Dis, Miami, FL USA
[3] Mem Blood Ctr, St Paul, MN USA
[4] John T Mather Mem Hosp, Port Jefferson, NY USA
[5] Univ Calif Los Angeles, Dept Med, Div Digest Disorders, Los Angeles, CA 90024 USA
[6] Cook Cty Hosp, Chicago, IL 60612 USA
[7] Parkland Mem Hosp & Affiliated Inst, Dallas, TX USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
B-32
引用
收藏
页码:A63 / A63
页数:1
相关论文
共 30 条
  • [21] DEVELOPMENT AND TRIAL OF A SOVIET DIAGNOSTIC KIT FOR THE DETECTION OF IGM TO HEPATITIS A VIRUS (HAV) BY MEANS OF THE ENZYME-IMMUNOASSAY (A TEST SYSTEM FOR ANTI-HAV IG)
    DONETS, MA
    NELGA, IV
    GRISHINA, GK
    KOROLEV, MB
    KUSOV, YY
    BALAYAN, MS
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1987, (09): : 75 - 81
  • [22] Performance of an automated chemiluminescent assay for the detection of anti-hepatitis A virus IgM antibodies:: Access® HAV IgM assay
    Buisson, Y.
    Masson, C.
    Bouniort, F.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S321 - S321
  • [23] Detection of anti-HAV and anti-HEV IgM in patients with sporadic acute hepatitis in Beijing between 1995-2000
    Jian Lu
    Hong-Lan Zhao
    Qing-Ling Meng
    Sheng-Dong Liao
    Yuan Wang
    Yong-Zhen Jiang From the Laboratory of Hepatitis
    Hepatobiliary & Pancreatic Diseases International, 2002, (01) : 83 - 86
  • [24] COMPARISON OF SOLID-PHASE TEST SYSTEMS FOR DEMONSTRATING ANTIBODIES AGAINST HEPATITIS-A VIRUS (ANTI-HAV) OF THE IGM-CLASS
    ROGGENDORF, M
    FROSNER, GG
    DEINHARDT, F
    SCHEID, R
    JOURNAL OF MEDICAL VIROLOGY, 1980, 5 (01) : 47 - 62
  • [25] Enriched high-titer human anti-hepatitis A virus (HAV) IgM for controls
    Sharma, H.
    Crush-Stanton, S.
    Moskowitz, K.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A54 - A55
  • [26] Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination
    Chen, Guan-Jhou
    Sun, Hsin-Yun
    Lin, Kuan-Yin
    Cheng, Aristine
    Huang, Yi-Chia
    Hsieh, Szu-Min
    Sheng, Wang-Huei
    Liu, Wen-Chun
    Hung, Chien-Ching
    Chang, Shan-Chwen
    LIVER INTERNATIONAL, 2018, 38 (07) : 1198 - 1205
  • [27] Multicenter outcomes-based evaluation of the Vitros® immunodiagnostic products Anti-HCV reagent pack and calibrator (Vitros Anti-HCV assay) in patients with signs and symptoms of hepatitis and in patients at risk for hepatitis C infection.
    Calcagno, JV
    Schiff, E
    Latimer, J
    Uettwiller-Geiger, D
    Attar, BM
    Gitnick, G
    Gorlin, JB
    Rodriguez, HJ
    Sze, G
    Schneider, H
    Peterson, J
    Bergmeyer, L
    HEPATOLOGY, 2001, 34 (04) : 231A - 231A
  • [28] Multi-center outcomes-based clinical evaluation of the VITROS® immunodiagnostic products Anti-HIV 1+2 assay* (VITROS Anti-HIV 1+2 assay) in subjects at high risk, low risk or positive for infection with human immunodeficiency virus types 1 and/or 2 (HIV-1 and/or HIV-2).
    Calcagno, J. V.
    Schiff, E.
    Gorlin, J.
    Yee, H. F., Jr.
    Kasahara, N.
    Soto-Gil, R.
    Bergmeyer, L.
    Schneider, H.
    Laird, E.
    Ajongwen, P.
    DeLucia, M.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A61 - A61
  • [29] Multicenter outcomes-based evaluation of the Vitros® Immunodiagnostic products anti-HBs reagent pack and calibrators (Vitros anti-HBs assay) in immunized patients and patients with signs and symptoms of hepatitis.
    Calcagno, JV
    Schiff, E
    Latimer, MJ
    Geiger, D
    Attar, B
    Gitnick, G
    Gorlin, JB
    Page, E
    Cummins, T
    CLINICAL CHEMISTRY, 2001, 47 (06) : A98 - A99
  • [30] MULTICENTER OUTCOMES-BASED CLINICAL EVALUATION OF THE VITROS® IMMUNODIAGNOSTIC PRODUCTS HBEAG AND ANTI-HBE ASSAYS FOR DETECTION OF HEPATITIS B E ANTIGEN (HBEAG) AND ANTIBODY TO HBEAG (ANTI-HBE) IN SUBJECTS AT HIGH RISK FOR VIRAL HEPATITIS
    Bergmeyer, Lynn
    Schiff, Eugene R.
    De Medina, Maria
    Janzen, Mark
    Uettwiller-Geiger, Denise
    Banks, Alpha T.
    Alvey, Stacey A.
    Wang, Songbai
    Calcagno, John V.
    HEPATOLOGY, 2010, 52 (04) : 565A - 565A